APOB and hyperlipidemia: Variants of APOB, which encodes the main lipoprotein in LDL-C, are associated with early onset AD (15), and overexpression of ApoB in mice results in hyperlipidemia, neurodegeneration, increased APP expression, and amyloid plaques (16, 17).